MBBS, FRCP, CCST (General Medicine, Diabetes and Endocrinology), DPhil (Oxon)

· Consultant Diabetologist, Endocrinologist, and Bariatric Physician

Clinical Lead for Obesity and for Genetics of Diabetes and Endocrinology,

Imperial College London Diabetes Centre, Abu Dhabi, UAE

· Organising committee member of the NIDDK/NIH coordinated global coalition for heterogeneity of diabetes and precision medicine

· Chairperson and joint UAE representative, MENA region working group, World Obesity Federation

· Director of the DOH upskilling course on obesity management

· Chairperson Integrated Health Section, International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) MENA – and member of the Executive Board for the Integrated Health Section, IFSO

· SCOPE International Fellow, World Obesity Federation

· European Association for the Study of Obesity (EASO), National Clinical Fellow

Dr Suliman received her specialist clinical and research training at the world-renowned Oxford Centre for Diabetes, Endocrinology and Metabolism, culminating in a DPhil (PhD) from Oxford University on the genetics and physiology of regional adipose deposition and insulin resistance. Her career has been shaped by her interest in genetic endocrine disorders (particularly in diabetes and obesity), physiology, insulin resistance and obesity. She has been a Consultant Endocrinologist, Diabetologist and Obesity Physician at Imperial College London Diabetes Centre, Abu Dhabi since 2012 where she currently leads the Genetics and Obesity services. She is a subject matter expert for the Department of Health (DOH) and Abu Dhabi Public Health Centre (ADPHC) for Diabetes, and Obesity. She is also the director of the DOH upskilling course on obesity management, with over 500 physicians trained to date.

She has set up and leads the Genetics of Diabetes, Obesity and Endocrine disorders clinic since 2014, providing a unique clinical service (in the UAE and MENA region) for patients with monogenic disorders including precision diagnosis, therapeutics (and personalised/targeted treatments), and prognosis; as well as early detection of affected family members through genetic testing and genetic counselling. Dr Suliman is an organising committee member of the NIDDK/NIH coordinated global coalition for heterogeneity of diabetes and precision medicine.

She also leads the multidisciplinary obesity-trained team provides the whole spectrum of obesity management, ranging from dietary and lifestyle interventions, to medication, to pre, peri and

post- metabolic bariatric surgery care, which is an European Association for the Study of Obesity (EASO) collaborating centre.

Dr Suliman is the elected Chairperson of the MENA obesity working group, and the first president of the soon to be launched Middle East and North Africa (MENA) obesity society. Dr Suliman has co-chaired the UAE Obesity conference since inception (2018), and helped develop it into the main regional conference for obesity. She is a co-founder and member of a Global Obesity Management Taskforce, set up to author joint World Obesity Federation and International Federation for Surgery of Obesity and Metabolic disorders (IFSO) evidence-based, comprehensive global obesity management guidelines to cater for countries with high, middle or low income, due to be published Dec 2025.

Dr Suliman has authored several papers, and presented her research at major international conferences. She contributed to the Oxford Handbook for Diabetes and Endocrinology and is a reviewer for leading medical journals. She co-authored the UAE guidelines for T2DM management (2020, being updated in 2025) commissioned by the Emirates Diabetes and Endocrinology Society; and the GCC and Lebanon obesity guidelines (2022), commissioned by the World Obesity Federation.